PTC Therapeutics (NASDAQ: PTCT) insider files Form 144 for 1,352 shares
Rhea-AI Filing Summary
A holder of PTCT common stock, identified as Eric Pauwels, has filed a notice of proposed sale under Rule 144. The notice covers 1,352 common shares to be sold through Fidelity Brokerage Services LLC, with an aggregate market value of $104,758.10 based on the filer’s calculation. The filing notes that 80,288,305 common shares were outstanding and lists the intended sale date as January 7, 2026 on the NASDAQ.
The 1,352 shares to be sold were acquired on January 5, 2026 through restricted stock vesting from the issuer as compensation. The notice also details prior sales of the issuer’s common stock by the same seller during the past three months, including 40,290 shares on December 17, 2025, 3,202 shares on December 18, 2025, 20,508 shares on December 19, 2025, and 1,789 shares on January 6, 2026, for gross proceeds of $3,038,755.33, $240,354.49, $1,584,387.54, and $137,659.26, respectively.
Positive
- None.
Negative
- None.